Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBimeda Incorporated, an animal and veterinary products manufacturer, received an FDA Warning Letter on January 31, 2019. While the specific violations cannot be determined from the available metadata, the letter indicates regulatory concerns related to the company's animal or veterinary products under FDA oversight. Based on limited information, the exact nature of the compliance issues and the specific FDA office responsible cannot be detailed further without access to the full warning letter text.